1. Home
  2. MDXG vs LMB Comparison

MDXG vs LMB Comparison

Compare MDXG & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • LMB
  • Stock Information
  • Founded
  • MDXG 2006
  • LMB 1901
  • Country
  • MDXG United States
  • LMB United States
  • Employees
  • MDXG N/A
  • LMB N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • LMB Engineering & Construction
  • Sector
  • MDXG Health Care
  • LMB Consumer Discretionary
  • Exchange
  • MDXG Nasdaq
  • LMB Nasdaq
  • Market Cap
  • MDXG 1.3B
  • LMB 1.1B
  • IPO Year
  • MDXG N/A
  • LMB 2014
  • Fundamental
  • Price
  • MDXG $8.79
  • LMB $102.44
  • Analyst Decision
  • MDXG Strong Buy
  • LMB Strong Buy
  • Analyst Count
  • MDXG 5
  • LMB 2
  • Target Price
  • MDXG $12.00
  • LMB $110.00
  • AVG Volume (30 Days)
  • MDXG 596.0K
  • LMB 189.5K
  • Earning Date
  • MDXG 02-26-2025
  • LMB 03-12-2025
  • Dividend Yield
  • MDXG N/A
  • LMB N/A
  • EPS Growth
  • MDXG N/A
  • LMB 29.01
  • EPS
  • MDXG 0.52
  • LMB 2.18
  • Revenue
  • MDXG $342,804,000.00
  • LMB $517,822,000.00
  • Revenue This Year
  • MDXG $9.56
  • LMB $2.59
  • Revenue Next Year
  • MDXG $9.19
  • LMB $12.46
  • P/E Ratio
  • MDXG $17.47
  • LMB $47.03
  • Revenue Growth
  • MDXG 10.93
  • LMB 0.13
  • 52 Week Low
  • MDXG $5.47
  • LMB $38.03
  • 52 Week High
  • MDXG $10.14
  • LMB $107.00
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 44.77
  • LMB 59.40
  • Support Level
  • MDXG $8.50
  • LMB $97.48
  • Resistance Level
  • MDXG $9.36
  • LMB $105.72
  • Average True Range (ATR)
  • MDXG 0.27
  • LMB 6.48
  • MACD
  • MDXG -0.02
  • LMB 1.12
  • Stochastic Oscillator
  • MDXG 33.72
  • LMB 82.11

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.

Share on Social Networks: